Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

BACKGROUND: Phambili, the Merck (MRK)-Adenovirus Type 5 (Ad5) HIV-1 gag/pol/nef subtype B vaccine study, conducted in South Africa, suspended enrollment and vaccination when companion study, Step, was found non-efficacious. Although the vaccine did not prevent HIV-1 infection or lower viral-load set...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hopkins, Kathryn L., Laher, Fatima, Otwombe, Kennedy, Churchyard, Gavin, Bekker, Linda-Gail, DeRosa, Stephen, Nchabeleng, Maphoshane, Mlisana, Koleka, Kublin, James, Gray, Glenda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121165/
https://ncbi.nlm.nih.gov/pubmed/25090110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0103446
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller